The FTSE 250 is full of solid operators, but few have QinetiQ’s (LSE: QQ) mix of long‑cycle defence contracts and quietly compounding earnings power.
Despite this, the market still seems slow to price in the scale and visibility of its future cash flows. That disconnect between operational strength and investor attention is exactly what catches my eye.
And it is why QinetiQ stands out for me as a genuine undervaluation opportunity. So, how undervalued is it?
How does growth momentum look?
A risk to QinetiQ’s earnings growth is any delay in government procurement or programme approvals due to defence strategy changes. Another is the company’s growing reliance on US expansion for margin improvement.
However, analysts forecast the high-tech defence firm’s profits will soar by an average of 76.1% a year to end-2028 at minimum.
In its 2025 results, orders increased 12% year on year to £1.955bn, illustrating strong customer appetite for QinetiQ’s unique capabilities.
Operational momentum was reinforced by securing £58m of laser‑weapon orders, delivering next‑generation tactical communications for the British Army, and achieving over 10% on‑contract growth across major US programmes.
Revenue remained buoyant at £1.932bn, underlining steady demand across its core defence assurance and mission‑data activities.
In its Q3 trading update, management said it forecasts earnings per share growth this fiscal year 2026 of 15%–20%. It also expects an operating margin of around 11%, supported by more than £3bn of orders secured year‑to‑date.
This included £87m of laser‑technology contracts and a £205m five‑year Typhoon engineering extension, which lifted the order backlog to around £5bn.
Where ‘should’ the shares be priced?
The discounted cash flow (DCF) model attempts to determine what a stock is truly worth by projecting future cash flows and discounting them back to today.
When those forecasts become more uncertain, investors demand higher returns, which increases the discount rate.
Because analysts’ DCF modelling varies on the assumptions used, valuation outcomes can differ. Nonetheless, based on my own modelling — including an 8.7 % discount rate — QinetiQ shares look 27% undervalued to me at their present level of £4.17.
That suggests a fair value of £5.71. So, if markets continue to move toward fair value, this could be a tremendous buying opportunity if those DCF assumptions prove accurate.
My investment view
QinetiQ’s combination of long‑cycle defence contracts and rising order visibility gives it unusually dependable future cash flows for a mid‑cap. Yet the shares still trade at a meaningful discount to the value implied by those cash flows.
With analysts expecting strong earnings growth and management guiding to higher margins, the gap between operational performance and market pricing looks increasingly hard to justify. I am not in a position to buy the stock myself, as I already have other defence-sector holdings (BAE Systems and Rolls-Royce). Adding another would unbalance the risk/reward ratio of my portfolio.
But for investors without that concern, the marked divergence between price and fair value merits serious attention, in my view.
Simon Watkins owns shares of BAE Systems and Rolls-Royce.
